Information Provided By: 
Fly News Breaks for June 5, 2015
TGTX
Jun 5, 2015 | 09:15 EDT
Roth Capital believes that TG's data reported at ASCO was "impressive," and the firm says that TG's '1101 and '1202 drugs have an emerging differentiated efficacy and safety profile. It keeps a Buy rtting on the stock and continues to identify it as a Focus Pick.
News For TGTX From the Last 2 Days
TGTX
Apr 19, 2024 | 10:46 EDT
Bullish option flow detected in TG Therapeutics with 1,058 calls trading, 1.2x expected, and implied vol increasing over 2 points to 100.79%. Jun-24 12 puts and Jun-24 17 calls are the most active options, with total volume in those strikes near 600 contracts. The Put/Call Ratio is 0.46. Earnings are expected on April 29th.
TGTX
Apr 18, 2024 | 12:48 EDT
TGTX
Apr 18, 2024 | 07:33 EDT
